Julie L. Hutson
University of Sheffield
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Julie L. Hutson.
Biochimica et Biophysica Acta | 1994
Anders Thelin; Elisabeth Peterson; Julie L. Hutson; Alun D. McCarthy; Johan Ericsson; Gustav Dallner
The effects of squalestatin 1 on rat brain and liver homogenates and on Chinese hamster ovary tissue culture cells have been investigated. This compound effectively inhibits squalene biosynthesis in a highly selective manner. Cytoplasmic farnesyl pyrophosphate and geranylgeranyl pyrophosphate synthases are not affected, which is also the case for microsomal cis-prenyltransferase. In tissue culture cells, squalestatin 1 inhibits cholesterol biosynthesis completely, but does not alter dolichol synthesis or protein isoprenylation to a great extent. Incorporation of [3H]mevalonate into ubiquinone-9 and -10 increases 3-4-fold, probably as a result of increased synthesis of this lipid. Squalestatin 1 appears not only to be an effective inhibitor of cholesterol biosynthesis, but also to be more specific than other inhibitors used earlier in various in vitro and in vivo systems.
Bioorganic & Medicinal Chemistry Letters | 1993
Nigel S. Watson; Richard Bell; Chuen Chan; Brian Cox; Julie L. Hutson; Suzanne Elaine Keeling; Barrie E. Kirk; Panayiotis A. Procopiou; Ian P. Steeples; Julia Widdowson
In squalestatins possessing at C6 either a 4,6-dimethyloctenoate ester or a hydroxyl group, the 5-carboxylic acid is crucial for squalene synthase inhibitory activity. In the former seires, free carboxylic acids are not required at C3 or C4 for potent enzyme inhibitory activity whereas in the latter series esterification of the carboxylic acids at C3 or C4 results in a significant reduction in enzyme inhibitory activity.
Biochimica et Biophysica Acta | 1985
Julie L. Hutson; Joan A. Higgins
Using trinitrobenzenesulphonic acid (TNBS) as a probe we have observed that phosphatidylethanolamine (PE) formed by base-exchange is initially concentrated in the cytosolic leaflet of the membrane bilayer. At 2 min, the specific activity of the PE in this leaflet was 3-times that of the PE in the cisternal leaflet. After 30 min, the specific activities of the two pools of PE, determined with either phospholipase C or TNBS, were similar. Transbilayer movement of PE was slow at low temperature, prevented by EDTA and restored by the addition of calcium ions after EDTA treatment. Trypsin treatment of microsomes, under conditions in which the vesicles remained closed, inhibited the incorporation of ethanolamine into PE by 87%. The cytosolic location of the ethanolamine base-exchange enzyme is consistent with the initial concentration of newly synthesised PE at this site prior to its transmembrane movement to the cisternal leaflet.
Bioorganic & Medicinal Chemistry Letters | 1994
Brian Cox; Julie L. Hutson; Suzanne Elaine Keeling; Barrie E. Kirk; Anton Rp Srikantha; Nigel S. Watson
A series of 3-hydroxymethyl derivatives of squalestatin 1 was prepared as inhibitors of squalene synthase. Potent in vitro inhibitory activity is retained in those analogues which possess C-6 and C-1 substituents analogous to those found in 1.
Bioorganic & Medicinal Chemistry Letters | 1994
Peter J Sharratt; Julie L. Hutson; Graham G. A. Inglis; Michael G. Lester; Panayiotis A. Procopiou; Nigel S. Watson
Abstract Monocyclic analogues of squalestatin 1 based on a 1,3-dioxane ring were prepared and evaluated for their ability to inhibit squalene synthase in vitro. The compound 16a possessing a 4,6-dimethyloctenoyloxymethyl group at C4 and a carboxamide at C2 showed similar inhibitory activity to 1.
Bioorganic & Medicinal Chemistry Letters | 1993
Panayiotis A. Procopiou; Esme Joan Bailey; Julie L. Hutson; Barrie E. Kirk; Peter J Sharratt; Stephen J. Spooner; Nigel S. Watson
Abstract Analogues of squalestatin 1 modified in th C1 side-chain were prepared and evaluated for their ability to inhibit squalene synthase in vitro. An appropriately substituted 6-phenylhexyl chain was found to be optimal for effective enzyme inhibition.
Bioscience Reports | 1987
Julie L. Hutson; Joan A. Higgins
Rat liver microsomes incorporate [14C]palmitoyl CoA into membrane phospholipids via the deacylation/acylation cycle. This activity is reversibly inactivated/activated by treatment of the microsomes with ATP, MgCl2, and 105,000g supernatant or with 105,000g supernatant alone. These observations suggest that the acylation cycle is controlled by a mechanism involving phosphorylation/dephosphorylation. As the pool of lysolecithin in the membranes is not altered by conditions increasing incorporation of palmitoyl CoA into phospholipid, it is probable that the site of regulation of deacylation/acylation is at the acyltransferase rather than the phospholipase.
FEBS Letters | 1985
Julie L. Hutson; Joan A. Higgins; K.W.A. Wirtz
Rat liver microsome Asymmetry Phosphatidylcholine Phospholipase C Phosphatidylcholine exchange protein Phosphatidylcholine pool
Biochimica et Biophysica Acta | 1982
Julie L. Hutson; Joan A. Higgins
Journal of Medicinal Chemistry | 1993
Panayiotis A. Procopiou; Christopher D. Draper; Julie L. Hutson; Graham G. A. Inglis; Barry C. Ross; Nigel S. Watson